Filing Details

Accession Number:
0001078782-21-000463
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-18 11:40:19
Reporting Period:
2021-05-14
Accepted Time:
2021-05-18 11:40:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1852492 Kim Nguyen 13215 Bee Cave Parkway
Suite 125, Galleria Oaks B
Austin TX 78738
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-14 2,000 $3.20 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,000 Direct
Common Stock 30,556 Indirect By Spouse
Footnotes
  1. These restricted stock units are subject to a 2-year vesting schedule, vesting as to 7,500 units on each of 03/25/22 and 03/25/23, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.